Global CAR T-Cell Therapy Agents Market Research Report 2026(Status and Outlook)
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global CAR T-Cell Therapy Agents market size was estimated at USD 414.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell Therapy Agents market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell Therapy Agents market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell Therapy Agents market.
Global CAR T-Cell Therapy Agents Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell Therapy Agents Market
Overview of the regional outlook of the CAR T-Cell Therapy Agents Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell Therapy Agents, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global CAR T-Cell Therapy Agents market size was estimated at USD 414.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell Therapy Agents market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell Therapy Agents market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell Therapy Agents market.
Global CAR T-Cell Therapy Agents Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell Therapy Agents Market
Overview of the regional outlook of the CAR T-Cell Therapy Agents Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Agents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell Therapy Agents, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy Agents
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Agents Segment by Type
1.2.2 CAR T-Cell Therapy Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY AGENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Agents Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell Therapy Agents Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY AGENTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell Therapy Agents Product Life Cycle
3.3 Global CAR T-Cell Therapy Agents Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell Therapy Agents Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell Therapy Agents Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell Therapy Agents Market Competitive Situation and Trends
3.8.1 CAR T-Cell Therapy Agents Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell Therapy Agents Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY AGENTS INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY AGENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell Therapy Agents Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell Therapy Agents Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Agents Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell Therapy Agents Market Size by Type (2020-2025)
6.4 Global CAR T-Cell Therapy Agents Price by Type (2020-2025)
7 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Agents Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell Therapy Agents Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL THERAPY AGENTS MARKET SALES BY REGION
8.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.2 Global CAR T-Cell Therapy Agents Sales Market Share by Region
8.2 Global CAR T-Cell Therapy Agents Market Size by Region
8.2.1 Global CAR T-Cell Therapy Agents Market Size by Region
8.2.2 Global CAR T-Cell Therapy Agents Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell Therapy Agents Sales by Country
8.3.2 North America CAR T-Cell Therapy Agents Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell Therapy Agents Sales by Country
8.4.2 Europe CAR T-Cell Therapy Agents Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell Therapy Agents Sales by Region
8.5.2 Asia Pacific CAR T-Cell Therapy Agents Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell Therapy Agents Sales by Country
8.6.2 South America CAR T-Cell Therapy Agents Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell Therapy Agents Sales by Region
8.7.2 Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL THERAPY AGENTS MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell Therapy Agents by Region(2020-2025)
9.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell Therapy Agents Production
9.4.1 North America CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell Therapy Agents Production
9.5.1 Europe CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell Therapy Agents Production (2020-2025)
9.6.1 Japan CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell Therapy Agents Production (2020-2025)
9.7.1 China CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell Therapy Agents Product Overview
10.1.3 Novartis CAR T-Cell Therapy Agents Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell Therapy Agents Product Overview
10.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell Therapy Agents Product Overview
10.4.3 J and J CAR T-Cell Therapy Agents Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell Therapy Agents Product Overview
10.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell Therapy Agents Product Overview
10.6.3 FOSUNKite CAR T-Cell Therapy Agents Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Basic Information
10.8.2 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
10.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.8.4 CARsgen Therapeutics Business Overview
10.8.5 CARsgen Therapeutics Recent Developments
10.9 Autolus Therapeutics
10.9.1 Autolus Therapeutics Basic Information
10.9.2 Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
10.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.9.4 Autolus Therapeutics Business Overview
10.9.5 Autolus Therapeutics Recent Developments
10.10 Sorrento Therapeutics
10.10.1 Sorrento Therapeutics Basic Information
10.10.2 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
10.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.10.4 Sorrento Therapeutics Business Overview
10.10.5 Sorrento Therapeutics Recent Developments
10.11 Mustang Bio
10.11.1 Mustang Bio Basic Information
10.11.2 Mustang Bio CAR T-Cell Therapy Agents Product Overview
10.11.3 Mustang Bio CAR T-Cell Therapy Agents Product Market Performance
10.11.4 Mustang Bio Business Overview
10.11.5 Mustang Bio Recent Developments
10.12 Bluebird Bio
10.12.1 Bluebird Bio Basic Information
10.12.2 Bluebird Bio CAR T-Cell Therapy Agents Product Overview
10.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product Market Performance
10.12.4 Bluebird Bio Business Overview
10.12.5 Bluebird Bio Recent Developments
10.13 Cellectis
10.13.1 Cellectis Basic Information
10.13.2 Cellectis CAR T-Cell Therapy Agents Product Overview
10.13.3 Cellectis CAR T-Cell Therapy Agents Product Market Performance
10.13.4 Cellectis Business Overview
10.13.5 Cellectis Recent Developments
10.14 Allogene Therapeutics
10.14.1 Allogene Therapeutics Basic Information
10.14.2 Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
10.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.14.4 Allogene Therapeutics Business Overview
10.14.5 Allogene Therapeutics Recent Developments
10.15 Celyad
10.15.1 Celyad Basic Information
10.15.2 Celyad CAR T-Cell Therapy Agents Product Overview
10.15.3 Celyad CAR T-Cell Therapy Agents Product Market Performance
10.15.4 Celyad Business Overview
10.15.5 Celyad Recent Developments
11 CAR T-CELL THERAPY AGENTS MARKET FORECAST BY REGION
11.1 Global CAR T-Cell Therapy Agents Market Size Forecast
11.2 Global CAR T-Cell Therapy Agents Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell Therapy Agents Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region
11.2.4 South America CAR T-Cell Therapy Agents Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell Therapy Agents by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell Therapy Agents Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell Therapy Agents by Type (2026-2035)
12.1.2 Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell Therapy Agents by Type (2026-2035)
12.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell Therapy Agents Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell Therapy Agents Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy Agents
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Agents Segment by Type
1.2.2 CAR T-Cell Therapy Agents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY AGENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Agents Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell Therapy Agents Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY AGENTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell Therapy Agents Product Life Cycle
3.3 Global CAR T-Cell Therapy Agents Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell Therapy Agents Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell Therapy Agents Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell Therapy Agents Market Competitive Situation and Trends
3.8.1 CAR T-Cell Therapy Agents Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell Therapy Agents Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY AGENTS INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Agents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY AGENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell Therapy Agents Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell Therapy Agents Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Agents Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell Therapy Agents Market Size by Type (2020-2025)
6.4 Global CAR T-Cell Therapy Agents Price by Type (2020-2025)
7 CAR T-CELL THERAPY AGENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Agents Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell Therapy Agents Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL THERAPY AGENTS MARKET SALES BY REGION
8.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.1 Global CAR T-Cell Therapy Agents Sales by Region
8.1.2 Global CAR T-Cell Therapy Agents Sales Market Share by Region
8.2 Global CAR T-Cell Therapy Agents Market Size by Region
8.2.1 Global CAR T-Cell Therapy Agents Market Size by Region
8.2.2 Global CAR T-Cell Therapy Agents Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell Therapy Agents Sales by Country
8.3.2 North America CAR T-Cell Therapy Agents Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell Therapy Agents Sales by Country
8.4.2 Europe CAR T-Cell Therapy Agents Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell Therapy Agents Sales by Region
8.5.2 Asia Pacific CAR T-Cell Therapy Agents Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell Therapy Agents Sales by Country
8.6.2 South America CAR T-Cell Therapy Agents Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell Therapy Agents Sales by Region
8.7.2 Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL THERAPY AGENTS MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell Therapy Agents by Region(2020-2025)
9.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell Therapy Agents Production
9.4.1 North America CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell Therapy Agents Production
9.5.1 Europe CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell Therapy Agents Production (2020-2025)
9.6.1 Japan CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell Therapy Agents Production (2020-2025)
9.7.1 China CAR T-Cell Therapy Agents Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell Therapy Agents Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell Therapy Agents Product Overview
10.1.3 Novartis CAR T-Cell Therapy Agents Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell Therapy Agents Product Overview
10.2.3 Gilead Sciences CAR T-Cell Therapy Agents Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell Therapy Agents Product Overview
10.4.3 J and J CAR T-Cell Therapy Agents Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell Therapy Agents Product Overview
10.5.3 JW Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell Therapy Agents Product Overview
10.6.3 FOSUNKite CAR T-Cell Therapy Agents Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Basic Information
10.8.2 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
10.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.8.4 CARsgen Therapeutics Business Overview
10.8.5 CARsgen Therapeutics Recent Developments
10.9 Autolus Therapeutics
10.9.1 Autolus Therapeutics Basic Information
10.9.2 Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
10.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.9.4 Autolus Therapeutics Business Overview
10.9.5 Autolus Therapeutics Recent Developments
10.10 Sorrento Therapeutics
10.10.1 Sorrento Therapeutics Basic Information
10.10.2 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
10.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.10.4 Sorrento Therapeutics Business Overview
10.10.5 Sorrento Therapeutics Recent Developments
10.11 Mustang Bio
10.11.1 Mustang Bio Basic Information
10.11.2 Mustang Bio CAR T-Cell Therapy Agents Product Overview
10.11.3 Mustang Bio CAR T-Cell Therapy Agents Product Market Performance
10.11.4 Mustang Bio Business Overview
10.11.5 Mustang Bio Recent Developments
10.12 Bluebird Bio
10.12.1 Bluebird Bio Basic Information
10.12.2 Bluebird Bio CAR T-Cell Therapy Agents Product Overview
10.12.3 Bluebird Bio CAR T-Cell Therapy Agents Product Market Performance
10.12.4 Bluebird Bio Business Overview
10.12.5 Bluebird Bio Recent Developments
10.13 Cellectis
10.13.1 Cellectis Basic Information
10.13.2 Cellectis CAR T-Cell Therapy Agents Product Overview
10.13.3 Cellectis CAR T-Cell Therapy Agents Product Market Performance
10.13.4 Cellectis Business Overview
10.13.5 Cellectis Recent Developments
10.14 Allogene Therapeutics
10.14.1 Allogene Therapeutics Basic Information
10.14.2 Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
10.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Product Market Performance
10.14.4 Allogene Therapeutics Business Overview
10.14.5 Allogene Therapeutics Recent Developments
10.15 Celyad
10.15.1 Celyad Basic Information
10.15.2 Celyad CAR T-Cell Therapy Agents Product Overview
10.15.3 Celyad CAR T-Cell Therapy Agents Product Market Performance
10.15.4 Celyad Business Overview
10.15.5 Celyad Recent Developments
11 CAR T-CELL THERAPY AGENTS MARKET FORECAST BY REGION
11.1 Global CAR T-Cell Therapy Agents Market Size Forecast
11.2 Global CAR T-Cell Therapy Agents Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell Therapy Agents Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region
11.2.4 South America CAR T-Cell Therapy Agents Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell Therapy Agents by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell Therapy Agents Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell Therapy Agents by Type (2026-2035)
12.1.2 Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell Therapy Agents by Type (2026-2035)
12.2 Global CAR T-Cell Therapy Agents Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell Therapy Agents Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell Therapy Agents Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 4. Global CAR T-Cell Therapy Agents Market Size by Application
Table 5. CAR T-Cell Therapy Agents Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell Therapy Agents Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell Therapy Agents Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell Therapy Agents Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2025)
Table 11. Global Market CAR T-Cell Therapy Agents Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell Therapy Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Agents Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell Therapy Agents Sales by Type (K MT)
Table 27. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 28. Global CAR T-Cell Therapy Agents Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell Therapy Agents Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell Therapy Agents Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell Therapy Agents Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell Therapy Agents Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell Therapy Agents Sales (K MT) by Application
Table 34. Global CAR T-Cell Therapy Agents Market Size by Application
Table 35. Global CAR T-Cell Therapy Agents Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell Therapy Agents Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell Therapy Agents Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell Therapy Agents Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell Therapy Agents Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell Therapy Agents Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell Therapy Agents Product Overview
Table 64. Novartis CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell Therapy Agents Product Overview
Table 70. Gilead Sciences CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell Therapy Agents Product Overview
Table 82. J and J CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 87. JW Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell Therapy Agents Product Overview
Table 92. FOSUNKite CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
Table 97. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. CARsgen Therapeutics Basic Information
Table 101. CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 102. CARsgen Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CARsgen Therapeutics Business Overview
Table 104. CARsgen Therapeutics Recent Developments
Table 105. Autolus Therapeutics Basic Information
Table 106. Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 107. Autolus Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Autolus Therapeutics Business Overview
Table 109. Autolus Therapeutics Recent Developments
Table 110. Sorrento Therapeutics Basic Information
Table 111. Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 112. Sorrento Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sorrento Therapeutics Business Overview
Table 114. Sorrento Therapeutics Recent Developments
Table 115. Mustang Bio Basic Information
Table 116. Mustang Bio CAR T-Cell Therapy Agents Product Overview
Table 117. Mustang Bio CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Mustang Bio Business Overview
Table 119. Mustang Bio Recent Developments
Table 120. Bluebird Bio Basic Information
Table 121. Bluebird Bio CAR T-Cell Therapy Agents Product Overview
Table 122. Bluebird Bio CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bluebird Bio Business Overview
Table 124. Bluebird Bio Recent Developments
Table 125. Cellectis Basic Information
Table 126. Cellectis CAR T-Cell Therapy Agents Product Overview
Table 127. Cellectis CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Cellectis Business Overview
Table 129. Cellectis Recent Developments
Table 130. Allogene Therapeutics Basic Information
Table 131. Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 132. Allogene Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Allogene Therapeutics Business Overview
Table 134. Allogene Therapeutics Recent Developments
Table 135. Celyad Basic Information
Table 136. Celyad CAR T-Cell Therapy Agents Product Overview
Table 137. Celyad CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Celyad Business Overview
Table 139. Celyad Recent Developments
Table 140. Global CAR T-Cell Therapy Agents Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global CAR T-Cell Therapy Agents Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific CAR T-Cell Therapy Agents Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global CAR T-Cell Therapy Agents Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global CAR T-Cell Therapy Agents Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global CAR T-Cell Therapy Agents Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global CAR T-Cell Therapy Agents Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 4. Global CAR T-Cell Therapy Agents Market Size by Application
Table 5. CAR T-Cell Therapy Agents Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell Therapy Agents Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell Therapy Agents Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell Therapy Agents Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2025)
Table 11. Global Market CAR T-Cell Therapy Agents Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell Therapy Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Agents Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell Therapy Agents Sales by Type (K MT)
Table 27. Global CAR T-Cell Therapy Agents Market Size by Type (M USD)
Table 28. Global CAR T-Cell Therapy Agents Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell Therapy Agents Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell Therapy Agents Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell Therapy Agents Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell Therapy Agents Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell Therapy Agents Sales (K MT) by Application
Table 34. Global CAR T-Cell Therapy Agents Market Size by Application
Table 35. Global CAR T-Cell Therapy Agents Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell Therapy Agents Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell Therapy Agents Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell Therapy Agents Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell Therapy Agents Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell Therapy Agents Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell Therapy Agents Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell Therapy Agents Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell Therapy Agents Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell Therapy Agents Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell Therapy Agents Product Overview
Table 64. Novartis CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell Therapy Agents Product Overview
Table 70. Gilead Sciences CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell Therapy Agents Product Overview
Table 82. J and J CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 87. JW Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell Therapy Agents Product Overview
Table 92. FOSUNKite CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Overview
Table 97. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. CARsgen Therapeutics Basic Information
Table 101. CARsgen Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 102. CARsgen Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CARsgen Therapeutics Business Overview
Table 104. CARsgen Therapeutics Recent Developments
Table 105. Autolus Therapeutics Basic Information
Table 106. Autolus Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 107. Autolus Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Autolus Therapeutics Business Overview
Table 109. Autolus Therapeutics Recent Developments
Table 110. Sorrento Therapeutics Basic Information
Table 111. Sorrento Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 112. Sorrento Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Sorrento Therapeutics Business Overview
Table 114. Sorrento Therapeutics Recent Developments
Table 115. Mustang Bio Basic Information
Table 116. Mustang Bio CAR T-Cell Therapy Agents Product Overview
Table 117. Mustang Bio CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Mustang Bio Business Overview
Table 119. Mustang Bio Recent Developments
Table 120. Bluebird Bio Basic Information
Table 121. Bluebird Bio CAR T-Cell Therapy Agents Product Overview
Table 122. Bluebird Bio CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Bluebird Bio Business Overview
Table 124. Bluebird Bio Recent Developments
Table 125. Cellectis Basic Information
Table 126. Cellectis CAR T-Cell Therapy Agents Product Overview
Table 127. Cellectis CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Cellectis Business Overview
Table 129. Cellectis Recent Developments
Table 130. Allogene Therapeutics Basic Information
Table 131. Allogene Therapeutics CAR T-Cell Therapy Agents Product Overview
Table 132. Allogene Therapeutics CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Allogene Therapeutics Business Overview
Table 134. Allogene Therapeutics Recent Developments
Table 135. Celyad Basic Information
Table 136. Celyad CAR T-Cell Therapy Agents Product Overview
Table 137. Celyad CAR T-Cell Therapy Agents Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Celyad Business Overview
Table 139. Celyad Recent Developments
Table 140. Global CAR T-Cell Therapy Agents Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global CAR T-Cell Therapy Agents Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific CAR T-Cell Therapy Agents Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific CAR T-Cell Therapy Agents Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa CAR T-Cell Therapy Agents Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa CAR T-Cell Therapy Agents Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global CAR T-Cell Therapy Agents Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global CAR T-Cell Therapy Agents Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global CAR T-Cell Therapy Agents Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global CAR T-Cell Therapy Agents Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global CAR T-Cell Therapy Agents Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CAR T-Cell Therapy Agents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Agents Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell Therapy Agents Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell Therapy Agents Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Agents Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell Therapy Agents Product Life Cycle
Figure 13. CAR T-Cell Therapy Agents Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell Therapy Agents Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Agents Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell Therapy Agents
Figure 19. Global CAR T-Cell Therapy Agents Market PEST Analysis
Figure 20. Global CAR T-Cell Therapy Agents Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell Therapy Agents Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell Therapy Agents by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell Therapy Agents by Type in 2025
Figure 29. Market Share of CAR T-Cell Therapy Agents by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell Therapy Agents by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell Therapy Agents Market Share by Application
Figure 33. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell Therapy Agents Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell Therapy Agents Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell Therapy Agents Market Share by Application in 2025
Figure 37. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell Therapy Agents Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell Therapy Agents Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell Therapy Agents Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell Therapy Agents Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 55. Germany CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell Therapy Agents Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell Therapy Agents Market Size by Region in 2024
Figure 68. China CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell Therapy Agents Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell Therapy Agents Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell Therapy Agents Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell Therapy Agents Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell Therapy Agents Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell Therapy Agents Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell Therapy Agents Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell Therapy Agents Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell Therapy Agents Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell Therapy Agents Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of CAR T-Cell Therapy Agents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Agents Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell Therapy Agents Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell Therapy Agents Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Agents Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell Therapy Agents Product Life Cycle
Figure 13. CAR T-Cell Therapy Agents Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell Therapy Agents Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell Therapy Agents Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Agents Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell Therapy Agents
Figure 19. Global CAR T-Cell Therapy Agents Market PEST Analysis
Figure 20. Global CAR T-Cell Therapy Agents Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell Therapy Agents Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell Therapy Agents by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell Therapy Agents by Type in 2025
Figure 29. Market Share of CAR T-Cell Therapy Agents by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell Therapy Agents by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell Therapy Agents Market Share by Application
Figure 33. Global CAR T-Cell Therapy Agents Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell Therapy Agents Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell Therapy Agents Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell Therapy Agents Market Share by Application in 2025
Figure 37. Global CAR T-Cell Therapy Agents Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell Therapy Agents Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell Therapy Agents Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell Therapy Agents Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell Therapy Agents Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell Therapy Agents Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell Therapy Agents Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 55. Germany CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell Therapy Agents Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell Therapy Agents Market Size by Region in 2024
Figure 68. China CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell Therapy Agents Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell Therapy Agents Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell Therapy Agents Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell Therapy Agents Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell Therapy Agents Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell Therapy Agents Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell Therapy Agents Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell Therapy Agents Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell Therapy Agents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell Therapy Agents Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell Therapy Agents Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell Therapy Agents Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell Therapy Agents Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell Therapy Agents Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell Therapy Agents Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell Therapy Agents Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell Therapy Agents Market Share Forecast by Application (2026-2035)
